VIA
IRWD icon

Virtus Investment Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Virtus Investment Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Buy
76,169
+1,858
+3% +$7.62K 0.07% 299
2025
Q4 		$250K Buy
+74,311
New +$193K 0.07% 333
2025
Q2 		– Sell
-100,851
Closed -$148K – 468
2025
Q1 		$148K Buy
+100,851
New +$240K 0.04% 336
2024
Q2 		– Sell
-21,173
Closed -$184K – 358
2024
Q1 		$184K Hold
21,173
– – 0.13% 199
2023
Q4 		$242K Hold
21,173
– – 0.18% 156
2023
Q3 		$204K Hold
21,173
– – 0.14% 174
2023
Q2 		$225K Buy
+21,173
New +$228K 0.15% 173

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Virtus Investment Advisers's IRWD Position: Q1 2026 in Review

Virtus Investment Advisers increased its Ironwood Pharmaceuticals (IRWD) stake by 2.5% in Q1 2026, buying an estimated $7.62K and bringing the position to 76,169 shares worth $267K. The position accounts for 0.07% of the portfolio, ranked #299.

Virtus Investment Advisers first reported a position in IRWD in Q2 2023 and has held it in 7 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Virtus Investment Advisers held 76,169 shares of Ironwood Pharmaceuticals worth $267K as of Q1 2026.
  • Virtus Investment Advisers bought 1,858 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $7.62K.
  • Ironwood Pharmaceuticals made up 0.07% of Virtus Investment Advisers's portfolio in Q1 2026, its #299 holding.
  • Virtus Investment Advisers first reported a position in Ironwood Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.